| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |